Linked Life Data

15747336

Source:http://linkedlifedata.com/resource/pubmed/id/15747336

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-5-2
pubmed:abstractText
Coronary heart disease is the leading cause of death among women of older age. Interest emerged as to whether premenopausal endogenous estrogen conferred cardiac protection and whether menopausal hormone therapy might prove beneficial. The results of pivotal clinical trials including the randomized, placebo-controlled hormone trial of the Women's Health Initiative (WHI) and the Heart and Estrogen/progestin Replacement Study (HERS) have led to new Guidelines from the American Heart Association (AHA) that state that hormone therapy should not be initiated or continued for the primary or secondary prevention of cardiovascular disease in menopausal women.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1545-5009
pubmed:author
pubmed:copyrightInfo
Copyright 2005 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
625-9
pubmed:dateRevised
2009-1-12
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Menopausal hormone therapy: currently no evidence for cardiac protection.
pubmed:affiliation
Division of Cardiology, Emory University School of Medicine; Grady Memorial Hospital; Emory Heart and Vascular Center, Atlanta, Georgia, USA. nwenger@emory.edu
pubmed:publicationType
Journal Article, Comparative Study, Review